Combined assessment of S‐ and N‐specificIL‐2 andIL‐13 secretion andCD69neo‐expression for discrimination of post–infection and post‐vaccination cellularSARS‐CoV‐2‐specific immune response

Author:

Kratzer Bernhard1ORCID,Schlax Larissa C.1,Gattinger Pia2ORCID,Waidhofer‐Söllner Petra1ORCID,Trapin Doris1,Tauber Peter A.1ORCID,Sehgal Al Nasar Ahmed1,Körmöczi Ulrike1,Rottal Arno1,Feichter Melanie1,Oberhofer Teresa1,Grabmeier‐Pfistershammer Katharina1ORCID,Borochova Kristina2,Dorofeeva Yulia2,Tulaeva Inna23ORCID,Weber Milena2ORCID,Mühl Bernhard4ORCID,Kropfmüller Anna5,Negrin Bettina5,Kundi Michael6ORCID,Valenta Rudolf2378ORCID,Pickl Winfried F.18ORCID

Affiliation:

1. Medical University of Vienna Center for Pathophysiology Infectiology and Immunology Institute of Immunology Vienna Austria

2. Medical University of Vienna Center for Pathophysiology, Infectiology and Immunology Department of Pathophysiology and Allergy Research Vienna Austria

3. I. M. Sechenov First Moscow State Medical University (Sechenov University) Department of Clinical Immunology and Allergology Laboratory for Immunopathology Moscow Russia

4. Labors.at Vienna Austria

5. Österreichische Gesundheitskasse, Klinikum Peterhof Baden Austria

6. Medical University of Vienna Center for Public Health Department for Environmental Health Vienna Austria

7. NRC Institute of Immunology FMBA of Russia Moscow Russia

8. Karl Landsteiner University of Health Sciences Krems Austria

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference65 articles.

1. A novel coronavirus outbreak of global health concern

2. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

3. A Novel Coronavirus from Patients with Pneumonia in China, 2019

4. COVID‐19: Lessons from SARS and MERS

5. World Health Organization (WHO).Coronavirus disease (COVID‐19) outbreak;2020.https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3